Recombinant Human MMP-2/CLG4A protein (His tag)

CAT:
763-PDEH100937-01
Size:
20 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Recombinant Human MMP-2/CLG4A protein (His tag) - image 1

Recombinant Human MMP-2/CLG4A protein (His tag)

  • Background:

    Matrix Metalloproteinase-2 (MMP-2) is an enzyme that degrades components of the extracellular matrix and thus plays a pivotal role in cell migration during physiological and pathological processes. MMP-2 expression is dependent on extracellular matrix metalloproteinase inducer (EMMPRIN), Her2/neu, growth factors, cytokines, and hormones. Pro-MMP-2 activation needs MT1-MMP and TIMP-2 contribution. MMP-2 is changed in distribution and increased in amount in the ventral cochlear nucleus after unilateral cochlear ablation. A low level of MMP-2 is linked to favorable prognosis in patients with a hormone receptor-negative tumor, usually associated with high risk. As a zymogen requiring proteolytic activation for catalytic activity, MMP-2 has been implicated broadly in the invasion and metastasis of many cancer model systems, including human breast cancer (HBC) . Blocking MMP-2 secretion and activation during breast carcinoma development may decrease metastasis. The detection of active MMP-2 alone or the rate of pro-MMP-2 and active MMP-2 is considered a very sensitive indicator of cancer metastasis. Modulation of MMP-2 expression and activation through specific inhibitors and activators may thus provide a new mechanism for breast cancer treatment.
  • Abbreviation:

    MMP-2; CLG4A
  • Synonyms:

    72 kDa Gelatinase;72 kDa Type IV Collagenase; CLG4; CLG4A; Gelatinase A; MMP-2; MMP-II; MMP2; MONA; Matrix Metalloproteinase-2; TBE-1
  • UniProt:

    P08253
  • Accession Number:

    P08253
  • Expression System:

    E.coli
  • Tag:

    N-His
  • Sequence:

    Lys 36-Gly 341
  • Field of Research:

    Cell biology; Cardiovascular; Cancer; metabolism
  • Endotoxin:

    < 10 EU/mg of the protein as determined by the LAL method.
  • Purity:

    > 95% as determined by reducing SDS-PAGE.
  • Bioactivity:

    Not validated for activity
  • Reconstitution:

    It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.
  • Shipping Conditions:

    This product is provided as lyophilized powder which is shipped with ice packs.
  • Storage Conditions:

    Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
  • Calculated Molecular Weight:

    33.6 kDa
  • Observed Molecular Weight:

    40 kDa
  • Species:

    Human